Use of parenteral prostanoids and outcomes in older patients with pulmonary arterial hypertension

17 May 2025 (08:00 - 12:45)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Giulio Savonitto

Karolinska Institutet, Stockholm (Italy)

4 More presentations in this session

Presentation thumbnail

Improving risk prediction in pulmonary hypertension: the role of pulmonary arterial compliance

Mr D. Inacio Cazeiro (Lisbon, PT)

Abstract Slides Video

Presentation thumbnail

TAPSE/PASP ratio: revealing the hidden predictor of pulmonary hypertension in acute pulmonary embolism

Doctor S. Esteves (Lisbon, PT)

Abstract Slides Video

Presentation thumbnail

The Failing Fontan: from the successful palliation to the unavoidable not-so-slowly progressive failure of the circuit

Doctor A. Pinho (Porto, PT)

Abstract Slides Video

Presentation thumbnail

Value of myocardial strain techniques for early diagnosis of pulmonary arterial hypertension in scleroderma patients

Doctor A. Reina (Seville, ES)

Abstract Slides Video

Access the full session

Session thumbnail

Breaking the pressure: innovations in pulmonary hypertension management

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025

You may be interested in

Congress Presentation

Infl uence Of Age In The Assessment Of Therapeutic Response In Patients With Pulmonary Arterial Hypertension

Congress Presentation

The role of age as a comorbidity in idiopathic and connective tissue disease-associated pulmonary arterial hypertension: from the Spanish Registry of Pulmonary Hypertension (REHAP Registry)

Congress Presentation

Echocardiographic assessment for responder analysis in pulmonary arterial hypertension patients treated with parenteral prostanoids

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources